🇺🇸 FDA
Patent

US 8110379

Targeted integration into the PPP1R12C locus

granted A61PA61P43/00

Quick answer

US patent 8110379 (Targeted integration into the PPP1R12C locus) held by Sangamo Biosciences, Inc. expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61P, A61P43/00